Standardized Physician-modified Fenestrated Endograft Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity Hospital Padova
About this trial
Multicenter retrospective study including all consecutive patients treated by PMEG using a standard modification technique of Valiant Captivia (Medtronic, Minneapolis, MN-USA).
Eligibility criteria
Qualifiers
Complex AAA (including short-neck AAA, JRAA, PRAA, extent IV TAAA)
Haemodynamic stability
Anatomical feasibility is based on the presence of a proximal aortic neck above the mid celiac trunk of ≥25 mm in length and between 18 mm and 35 mm in diameter; the neck needs to be "healthy" with no parietal calcifications or thrombus with a cylindrical shape. The visceral aorta is required to be no larger than 40 mm in maximum diameter.
Disqualifiers
Extent I-III TAAA
Hemorrhagic shock
Trial design
Treatments tested in this trial
- Physician-modification of Valiant Captivia Endograft (Medtronic, Minneapolis, MN-USA).
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov